Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells

Autores
Rodríguez, José A.; Luria Pérez, Rosendo; López Valdés, Héctor E.; Casero, David; Daniels, Tracy R.; Patel, Shabnum; Avila, David; Leuchter, Richard; So, Sokuntheavy; Ortiz Sánchez, Elizabeth; Bonavida, Benjamin; Martínez Maza, Otoniel; Charles, Andrew C.; Pellegrini, Matteo; Helguera, Gustavo Fernando; Penichet, Manuel L.
Año de publicación
2011
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
A number of antibodies have been developed that induce lethal iron deprivation (LID) by targeting the transferrin receptor 1 (TfR1/CD71) and either neutralizing transferrin (Tf) binding, blocking internalization of the receptor and/or inducing its degradation. We have developed recombinant antibodies targeting human TfR1 (ch128.1 and ch128.1Av), which induce receptor degradation and are cytotoxic to certain malignant B-cells. We now show that internalization of TfR1 bound to these antibodies can lead to its sequestration and degradation, as well as reduced Tf uptake, and the induction of a transcriptional response consistent with iron deprivation, which is mediated in part by downstream targets of p53. Cells resistant to these antibodies do not sequester and degrade TfR1 after internalization of the antibody/receptor complex, and accordingly maintain their ability to internalize Tf. These findings are expected to facilitate the rational design and clinical use of therapeutic agents targeting iron import via TfR1 in hematopoietic malignancies.
Fil: Rodríguez, José A.. University of California at Los Angeles; Estados Unidos
Fil: Luria Pérez, Rosendo. University of California at Los Angeles; Estados Unidos. Hospital infantil de México “Federico Gómez”; México
Fil: López Valdés, Héctor E.. University of California at Los Angeles; Estados Unidos
Fil: Casero, David. University of California at Los Angeles; Estados Unidos
Fil: Daniels, Tracy R.. University of California at Los Angeles; Estados Unidos
Fil: Patel, Shabnum. University of California at Los Angeles; Estados Unidos
Fil: Avila, David. University of California at Los Angeles; Estados Unidos
Fil: Leuchter, Richard. University of California at Los Angeles; Estados Unidos
Fil: So, Sokuntheavy. University of California at Los Angeles; Estados Unidos
Fil: Ortiz Sánchez, Elizabeth. University of California at Los Angeles; Estados Unidos
Fil: Bonavida, Benjamin. University of California at Los Angeles; Estados Unidos
Fil: Martínez Maza, Otoniel. University of California at Los Angeles; Estados Unidos
Fil: Charles, Andrew C.. University of California at Los Angeles; Estados Unidos
Fil: Pellegrini, Matteo. University of California at Los Angeles; Estados Unidos
Fil: Helguera, Gustavo Fernando. University of California at Los Angeles; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
Fil: Penichet, Manuel L.. University of California at Los Angeles; Estados Unidos
Materia
Transferrin,
Monoclonal Antibody
iron deprivation
Cancer
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/12909

id CONICETDig_c2d0ce8d32344d7ef144d2828dd81848
oai_identifier_str oai:ri.conicet.gov.ar:11336/12909
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cellsRodríguez, José A.Luria Pérez, RosendoLópez Valdés, Héctor E.Casero, DavidDaniels, Tracy R.Patel, ShabnumAvila, DavidLeuchter, RichardSo, SokuntheavyOrtiz Sánchez, ElizabethBonavida, BenjaminMartínez Maza, OtonielCharles, Andrew C.Pellegrini, MatteoHelguera, Gustavo FernandoPenichet, Manuel L.Transferrin,Monoclonal Antibodyiron deprivationCancerhttps://purl.org/becyt/ford/3.4https://purl.org/becyt/ford/3A number of antibodies have been developed that induce lethal iron deprivation (LID) by targeting the transferrin receptor 1 (TfR1/CD71) and either neutralizing transferrin (Tf) binding, blocking internalization of the receptor and/or inducing its degradation. We have developed recombinant antibodies targeting human TfR1 (ch128.1 and ch128.1Av), which induce receptor degradation and are cytotoxic to certain malignant B-cells. We now show that internalization of TfR1 bound to these antibodies can lead to its sequestration and degradation, as well as reduced Tf uptake, and the induction of a transcriptional response consistent with iron deprivation, which is mediated in part by downstream targets of p53. Cells resistant to these antibodies do not sequester and degrade TfR1 after internalization of the antibody/receptor complex, and accordingly maintain their ability to internalize Tf. These findings are expected to facilitate the rational design and clinical use of therapeutic agents targeting iron import via TfR1 in hematopoietic malignancies.Fil: Rodríguez, José A.. University of California at Los Angeles; Estados UnidosFil: Luria Pérez, Rosendo. University of California at Los Angeles; Estados Unidos. Hospital infantil de México “Federico Gómez”; MéxicoFil: López Valdés, Héctor E.. University of California at Los Angeles; Estados UnidosFil: Casero, David. University of California at Los Angeles; Estados UnidosFil: Daniels, Tracy R.. University of California at Los Angeles; Estados UnidosFil: Patel, Shabnum. University of California at Los Angeles; Estados UnidosFil: Avila, David. University of California at Los Angeles; Estados UnidosFil: Leuchter, Richard. University of California at Los Angeles; Estados UnidosFil: So, Sokuntheavy. University of California at Los Angeles; Estados UnidosFil: Ortiz Sánchez, Elizabeth. University of California at Los Angeles; Estados UnidosFil: Bonavida, Benjamin. University of California at Los Angeles; Estados UnidosFil: Martínez Maza, Otoniel. University of California at Los Angeles; Estados UnidosFil: Charles, Andrew C.. University of California at Los Angeles; Estados UnidosFil: Pellegrini, Matteo. University of California at Los Angeles; Estados UnidosFil: Helguera, Gustavo Fernando. University of California at Los Angeles; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: Penichet, Manuel L.. University of California at Los Angeles; Estados UnidosTaylor & Francis Ltd2011-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/12909Rodríguez, José A.; Luria Pérez, Rosendo; López Valdés, Héctor E.; Casero, David; Daniels, Tracy R.; et al.; Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells; Taylor & Francis Ltd; Leukemia And Lymphoma; 52; 11; 11-2011; 2169-21781042-8194enginfo:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/abs/10.3109/10428194.2011.596964?journalCode=ilal20info:eu-repo/semantics/altIdentifier/doi/10.3109/10428194.2011.596964info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732792/info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:23:11Zoai:ri.conicet.gov.ar:11336/12909instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:23:11.363CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
title Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
spellingShingle Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
Rodríguez, José A.
Transferrin,
Monoclonal Antibody
iron deprivation
Cancer
title_short Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
title_full Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
title_fullStr Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
title_full_unstemmed Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
title_sort Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells
dc.creator.none.fl_str_mv Rodríguez, José A.
Luria Pérez, Rosendo
López Valdés, Héctor E.
Casero, David
Daniels, Tracy R.
Patel, Shabnum
Avila, David
Leuchter, Richard
So, Sokuntheavy
Ortiz Sánchez, Elizabeth
Bonavida, Benjamin
Martínez Maza, Otoniel
Charles, Andrew C.
Pellegrini, Matteo
Helguera, Gustavo Fernando
Penichet, Manuel L.
author Rodríguez, José A.
author_facet Rodríguez, José A.
Luria Pérez, Rosendo
López Valdés, Héctor E.
Casero, David
Daniels, Tracy R.
Patel, Shabnum
Avila, David
Leuchter, Richard
So, Sokuntheavy
Ortiz Sánchez, Elizabeth
Bonavida, Benjamin
Martínez Maza, Otoniel
Charles, Andrew C.
Pellegrini, Matteo
Helguera, Gustavo Fernando
Penichet, Manuel L.
author_role author
author2 Luria Pérez, Rosendo
López Valdés, Héctor E.
Casero, David
Daniels, Tracy R.
Patel, Shabnum
Avila, David
Leuchter, Richard
So, Sokuntheavy
Ortiz Sánchez, Elizabeth
Bonavida, Benjamin
Martínez Maza, Otoniel
Charles, Andrew C.
Pellegrini, Matteo
Helguera, Gustavo Fernando
Penichet, Manuel L.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Transferrin,
Monoclonal Antibody
iron deprivation
Cancer
topic Transferrin,
Monoclonal Antibody
iron deprivation
Cancer
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.4
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv A number of antibodies have been developed that induce lethal iron deprivation (LID) by targeting the transferrin receptor 1 (TfR1/CD71) and either neutralizing transferrin (Tf) binding, blocking internalization of the receptor and/or inducing its degradation. We have developed recombinant antibodies targeting human TfR1 (ch128.1 and ch128.1Av), which induce receptor degradation and are cytotoxic to certain malignant B-cells. We now show that internalization of TfR1 bound to these antibodies can lead to its sequestration and degradation, as well as reduced Tf uptake, and the induction of a transcriptional response consistent with iron deprivation, which is mediated in part by downstream targets of p53. Cells resistant to these antibodies do not sequester and degrade TfR1 after internalization of the antibody/receptor complex, and accordingly maintain their ability to internalize Tf. These findings are expected to facilitate the rational design and clinical use of therapeutic agents targeting iron import via TfR1 in hematopoietic malignancies.
Fil: Rodríguez, José A.. University of California at Los Angeles; Estados Unidos
Fil: Luria Pérez, Rosendo. University of California at Los Angeles; Estados Unidos. Hospital infantil de México “Federico Gómez”; México
Fil: López Valdés, Héctor E.. University of California at Los Angeles; Estados Unidos
Fil: Casero, David. University of California at Los Angeles; Estados Unidos
Fil: Daniels, Tracy R.. University of California at Los Angeles; Estados Unidos
Fil: Patel, Shabnum. University of California at Los Angeles; Estados Unidos
Fil: Avila, David. University of California at Los Angeles; Estados Unidos
Fil: Leuchter, Richard. University of California at Los Angeles; Estados Unidos
Fil: So, Sokuntheavy. University of California at Los Angeles; Estados Unidos
Fil: Ortiz Sánchez, Elizabeth. University of California at Los Angeles; Estados Unidos
Fil: Bonavida, Benjamin. University of California at Los Angeles; Estados Unidos
Fil: Martínez Maza, Otoniel. University of California at Los Angeles; Estados Unidos
Fil: Charles, Andrew C.. University of California at Los Angeles; Estados Unidos
Fil: Pellegrini, Matteo. University of California at Los Angeles; Estados Unidos
Fil: Helguera, Gustavo Fernando. University of California at Los Angeles; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
Fil: Penichet, Manuel L.. University of California at Los Angeles; Estados Unidos
description A number of antibodies have been developed that induce lethal iron deprivation (LID) by targeting the transferrin receptor 1 (TfR1/CD71) and either neutralizing transferrin (Tf) binding, blocking internalization of the receptor and/or inducing its degradation. We have developed recombinant antibodies targeting human TfR1 (ch128.1 and ch128.1Av), which induce receptor degradation and are cytotoxic to certain malignant B-cells. We now show that internalization of TfR1 bound to these antibodies can lead to its sequestration and degradation, as well as reduced Tf uptake, and the induction of a transcriptional response consistent with iron deprivation, which is mediated in part by downstream targets of p53. Cells resistant to these antibodies do not sequester and degrade TfR1 after internalization of the antibody/receptor complex, and accordingly maintain their ability to internalize Tf. These findings are expected to facilitate the rational design and clinical use of therapeutic agents targeting iron import via TfR1 in hematopoietic malignancies.
publishDate 2011
dc.date.none.fl_str_mv 2011-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/12909
Rodríguez, José A.; Luria Pérez, Rosendo; López Valdés, Héctor E.; Casero, David; Daniels, Tracy R.; et al.; Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells; Taylor & Francis Ltd; Leukemia And Lymphoma; 52; 11; 11-2011; 2169-2178
1042-8194
url http://hdl.handle.net/11336/12909
identifier_str_mv Rodríguez, José A.; Luria Pérez, Rosendo; López Valdés, Héctor E.; Casero, David; Daniels, Tracy R.; et al.; Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells; Taylor & Francis Ltd; Leukemia And Lymphoma; 52; 11; 11-2011; 2169-2178
1042-8194
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/abs/10.3109/10428194.2011.596964?journalCode=ilal20
info:eu-repo/semantics/altIdentifier/doi/10.3109/10428194.2011.596964
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732792/
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Taylor & Francis Ltd
publisher.none.fl_str_mv Taylor & Francis Ltd
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614225892212736
score 13.070432